Tuesday, November 26, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
OMNIQ
Cybersecurity

OMNIQ (OMQS) $5.00 Reports $15.8 Million 3Q, up 21%.

Editor / Curator -
OMQS
Cybersecurity

Adding OmniQ (OMQS) $5.00 to the Watch List.

Editor / Curator -
Hapbee
Telehealth

Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.

Editor / Curator -
All News

Adding Galaxy Digital (GLXY) $5.19 to Watch List.

Editor / Curator -
Dyadic, Biotech Stock Review
2020 Watch List

Dyadic (DYAI) Price Target $12.

Editor / Curator -
Incubator

Dalrada (DFCO) Removes Shell Company Status.

Editor / Curator -
Dalrada, Biotech Stock Review
Incubator

Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC

Editor / Curator -
Teledoc, Biotech Stock Review
Telehealth

Nothing Quite Like Telehealth. Teledoc (TDOC) Price Targets Raised.

Editor / Curator -
Hapbee, Biotech Stock Review
All News

Hapbee Technologies (HAPB): Updates and News Archive.

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Hapbee (HAPB) Soars 136% the First Day of Trading!

Editor / Curator -
1...575859...93Page 58 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.